NCT05469230

Brief Summary

This study aims to:

  • Assess the cognitive function in children with beta thalassemia
  • Evaluate the fatigue in beta thalassemic children
  • Assess the health related quality of life measures in children with beta thalassemia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
168

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2022

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 19, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 21, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2023

Completed
Last Updated

June 22, 2023

Status Verified

July 1, 2022

Enrollment Period

1.3 years

First QC Date

July 19, 2022

Last Update Submit

June 20, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • assessing the change in cognitive function

    assessing the change in verbal comprehension, perceptual reasoning, processing speed, working memory and total IQ using Wecshler Intelligence Scale for Children (4th edition)

    baseline to 6 months

  • Assessing the change in fatigue

    assessing the change in General Fatigue,Sleep/Rest Fatigue and Cognitive Fatigue using Pediatric quality of life inventory multidimensional fatigue scale (child report)

    Baseline to 6 months

  • Assessing the change in health related quality of life

    assessing the change in physical, emotional, social and school functioning domains using the Pediatric quality of life inventory Generic core scale (child report) (version 4)

    Baseline to 6 months

Study Arms (2)

Typically developed children group

Typically developed children will be from both genders. the age range will be (8-16) years old and will be recruited from public governmental schools

Beta thalassemia group

children diagnosed with beta thalassemia major and intermedia will be recruited from Abo-El-Rish Pediatric Hospital. the age will be (8-16) years and will be from both genders

Eligibility Criteria

Age8 Years - 16 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

* Children diagnosed with beta thalassemia will be recruited from Abo El-Rish Pediatric Hospital .(Cairo University Hospitals) * Both genders will be included * Their age range from 8 to 16 years old shouldn't have any associated diseases with beta thalassemia

You may qualify if:

  • Beta thalassemia group (Study group): Both genders will be included and their age range from 8 to 16 years old
  • Typically developed children (control group):
  • Healthy children will be recruited from public governmental schools
  • Healthy controls, matching the patients in age, gender and educational level.
  • It will be ensured from their past medical history and clinical examination that they and their first-degree relatives never had any chronic disease, including thalassemia.
  • Both genders will be included
  • Their age range from 8 to 16 years old

You may not qualify if:

  • Beta thalassemia group (study group): Any child Suffering from any other chronic diseases other than thalassemia
  • Having visual or auditory problems
  • Typically developed children (control group):
  • any child suffering from medical illness, musculoskeletal deformities, visual and auditory problems.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Abo El-Rish Pediatric Hospital

Giza, Egypt

Location

MeSH Terms

Conditions

beta-ThalassemiaFatigue

Condition Hierarchy (Ancestors)

ThalassemiaAnemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Esraa ibrahim, M.Sc

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

July 19, 2022

First Posted

July 21, 2022

Study Start

January 15, 2022

Primary Completion

April 30, 2023

Study Completion

May 30, 2023

Last Updated

June 22, 2023

Record last verified: 2022-07

Locations